Related Experiment Videos
[Subacute myelogenous leukemia with Phildelphia chromosome]
Nouvelle Revue Francaise D'Hematologie
|July 1, 1975
Summary
This study identifies a distinct leukemia subtype, subacute myeloid leukemia Ph1 positive (L.M.S. Ph1+), characterized by excess blasts and Ph1 chromosome. L.M.S. Ph1+ presents a more severe clinical course than typical chronic myeloid leukemia.
Area of Science:
- Hematology
- Oncology
- Cytogenetics
Context:
- Chronic myeloid leukemia (C.M.L.) typically follows a predictable course.
- A subset of patients presents with features distinct from classical C.M.L.
- The presence of the Ph1 chromosome is a hallmark of C.M.L. but can also be found in other myeloid malignancies.
Purpose:
- To describe a unique pattern of chronic myeloid leukemia with excessive blasts.
- To propose a new appellation, subacute myeloid leukemia Ph1 positive (L.M.S. Ph1+), for these cases.
- To differentiate L.M.S. Ph1+ from other related myeloid leukemias.
Summary:
- Reports on 25 cases of a leukemia variant characterized by myeloblasts >= 20%, Ph1 chromosome, and short survival (median 14.5 months).
- Clinical presentation includes fever, bone pain, and anemia, with frequent myelofibrosis and abnormal platelets/megakaryocytes.
- L.M.S. Ph1+ is distinguished by Ph1 chromosome, blast excess, and bone marrow fibrosis, differentiating it from C.M.L. with myelofibrosis, Ph1-positive myelofibrosis with myeloid metaplasia, and Ph1-positive acute leukemia.
Impact:
- Establishes L.M.S. Ph1+ as a distinct clinical entity within myeloid leukemias.
- Provides criteria for differentiating L.M.S. Ph1+ from other leukemias, aiding diagnosis.
- Suggests a poorer prognosis than C.M.L. but potentially better than acute blastic crisis, informing treatment strategies.